Abstract
Long-term audit of PCSK9 inhibitor therapy: impacts on LDL-C and HbA1c in clinical practice
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have